The latest price target for HealthEquity (NASDAQ:HQY) was reported by JMP Securities on December 10, 2024. The analyst firm set a price target for $107.00 expecting HQY to rise to within 12 months (a possible 2.16% upside). 33 analyst firms have reported ratings in the last year.

The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by JMP Securities, and HealthEquity maintained their market outperform rating.

The last upgrade for HealthEquity Inc happened on September 21, 2023 when Baird raised their price target to $87. Baird previously had a neutral for HealthEquity Inc.

There is no last downgrade for HealthEquity.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.

While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $105.00 to $107.00. The current price HealthEquity (HQY) is trading at is $104.74, which is out of the analyst’s predicted range.